Infectious Disease: Dengue Surges, Blastomycosis Expands, TMVII Outbreak, TB Sequencing Advances

Global health authorities are monitoring several infectious disease developments. Dengue cases are surging globally, with traveler-associated cases reaching record highs. Blastomycosis is expanding its endemic range into New York State. Simultaneously, a TMVII fungal outbreak is under investigation in Minnesota, and advancements in rapid TB sequencing offer hope for improved diagnosis and treatment of tuberculosis. ## Latest Update The latest data highlights the effectiveness of home-based monitoring for drug-resistant tuberculosis (DR-TB) treatment in India. A study showed that community health workers detected more adverse events, leading to timely interventions and better patient outcomes, emphasizing the importance of community-level healthcare infrastructure in managing the DR-TB crisis. ## Timeline * **2026-02-14:** A study in Bangladesh reveals that the 2023 dengue outbreak, the deadliest in the country's history, significantly expanded into non-endemic areas, highlighting healthcare challenges and higher fatality rates among females and the elderly. * **2026-02-16:** CDC analysis of travel-associated dengue cases from 2010-2024 indicates a surge in global transmission risk, with 2024 seeing a record peak. Traveler data effectively identifies transmission spikes, even in countries with limited local reporting. * **2026-02-16:** An outbreak of TMVII is reported in Minnesota, along with a rare human case of Streptococcus parasuis in China, and the use of travel-associated dengue cases as an early warning system. * **2026-02-26:** Surveillance data indicates a steady increase in blastomycosis cases within New York State from 2000 to 2024, suggesting a shift or expansion of the environmental niche for Blastomyces. * **2026-02-26:** A study in Mozambique found that Tuberculosis Preventive Therapy (TPT) among people living with HIV (PLHIV) who were also initiating Antiretroviral Therapy (ART) had a persistent incidence of TB disease in this cohort. * **2026-03-02:** Researchers at Yale are applying rapid genomic sequencing to analyze TB samples, providing actionable intelligence on drug resistance within 24-48 hours, significantly faster than traditional methods. * **2026-03-05:** A study in India showed that home-based monitoring of patients undergoing treatment for drug-resistant tuberculosis (DR-TB) detected a higher volume of adverse events, leading to timely interventions and better patient outcomes. ## What to Watch * **Dengue Spread:** Continue monitoring dengue transmission patterns, especially in regions with limited reporting capacity, and prepare for potential outbreaks. * **Blastomycosis Expansion:** Monitor the geographic expansion of blastomycosis and increase awareness among healthcare providers in newly affected areas to prevent misdiagnosis. * **TB Sequencing Implementation:** Track the adoption and impact of rapid TB sequencing technologies on treatment outcomes and the spread of drug-resistant strains.